Literature DB >> 18573343

Fas-associated factor 1 and Parkinson's disease.

Ranjita Betarbet1, Leah R Anderson, Marla Gearing, Tiffany R Hodges, Jason J Fritz, James J Lah, Allan I Levey.   

Abstract

Fas-associated factor 1 or FAF1 is a Fas-binding protein implicated in apoptosis. FAF1 is the product of a gene at PARK 10 locus on chromosome 1p32, a locus associated with late-onset PD [Hicks, A.A., Petursson, H., Jonsson, T., Stefansson, H., Johannsdottir, H.S., Sainz, J., Frigge, M.L.et al., 2002. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol. 52, 549-555.]. In the present study we investigated the role of FAF1 in cell death and in Parkinson's disease (PD) pathogenesis. FAF1 levels were significantly increased in frontal cortex of PD as well as in PD cases with Alzheimer's disease (AD) pathology compared to control cases. Changes in FAF1 expression were specific to PD-related alpha-synuclein pathology and nigral cell loss. In addition, PD-related insults including, mitochondrial complex I inhibition, oxidative stress, and increased alpha-synuclein expression specifically increased endogenous FAF1 expression in vitro. Increased FAF1 levels induced cell death and significantly potentiated toxic effects of PD-related stressors including, oxidative stress, mitochondrial complex I inhibition and proteasomal inhibition. These studies, together with previous genetic linkage studies, highlight the potential significance of FAF1 in pathogenesis of idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573343      PMCID: PMC2615003          DOI: 10.1016/j.nbd.2008.05.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  29 in total

Review 1.  Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

Authors:  D J Selkoe
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Cognitive decline correlates with neuropathological stage in Parkinson's disease.

Authors:  Heiko Braak; Udo Rüb; Kelly Del Tredici
Journal:  J Neurol Sci       Date:  2006-06-30       Impact factor: 3.181

3.  Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

Authors:  Magali Periquet; Tudor Fulga; Liisa Myllykangas; Michael G Schlossmacher; Mel B Feany
Journal:  J Neurosci       Date:  2007-03-21       Impact factor: 6.167

4.  Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.

Authors:  Ranjita Betarbet; Rosa M Canet-Aviles; Todd B Sherer; Pier G Mastroberardino; Chris McLendon; Jin-Ho Kim; Serena Lund; Hye-Mee Na; Georgia Taylor; Neil F Bence; Ron Kopito; Byoung Boo Seo; Takao Yagi; Akemi Yagi; Gary Klinefelter; Mark R Cookson; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2006-01-24       Impact factor: 5.996

5.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

6.  Apoptosis induced by human Fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain.

Authors:  S W Ryu; E Kim
Journal:  Biochem Biophys Res Commun       Date:  2001-09-07       Impact factor: 3.575

7.  The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.

Authors:  Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

8.  Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.

Authors:  A L McCormack; J G Atienza; J W Langston; D A Di Monte
Journal:  Neuroscience       Date:  2006-05-04       Impact factor: 3.590

9.  Dopamine miracle: from brain homogenate to dopamine replacement.

Authors:  Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

10.  Merging mouse transcriptome analyses with Parkinson's disease linkage studies.

Authors:  Daniel Gherbassi; Lavinia Bhatt; Sandrine Thuret; Horst H Simon
Journal:  DNA Res       Date:  2007-05-23       Impact factor: 4.458

View more
  17 in total

1.  The contribution of Cdc2 in rotenone-induced G2/M arrest and caspase-3-dependent apoptosis.

Authors:  Hongcai Wang; Zhentao Zhang; Jinsha Huang; Ping Zhang; Nian Xiong; Tao Wang
Journal:  J Mol Neurosci       Date:  2013-12-12       Impact factor: 3.444

2.  Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.

Authors:  Elaine L Pranski; Carson D Van Sanford; Nirjari V Dalal; Adam L Orr; Dipan Karmali; Deborah S Cooper; Nichole Costa; Craig J Heilman; Marla Gearing; James J Lah; Allan I Levey; Ranjita S Betarbet
Journal:  Neurosci Lett       Date:  2012-05-23       Impact factor: 3.046

3.  Fas-associated factor 1 as a regulator of olfactory axon guidance.

Authors:  Kai Cheng; Li Bai; Leonardo Belluscio
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

Review 4.  Genetic determinants of neuronal vulnerability to apoptosis.

Authors:  Angeles Almeida
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

Review 5.  FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis.

Authors:  Craig W Menges; Deborah A Altomare; Joseph R Testa
Journal:  Cell Cycle       Date:  2009-08-16       Impact factor: 4.534

6.  Crystallization and preliminary X-ray crystallographic analysis of human FAF1 UBX domain.

Authors:  Wonchull Kang; Hwa Young Shin; Jin Kuk Yang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-01-28

7.  FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration.

Authors:  Changsun Yu; Bok-Seok Kim; Eunhee Kim
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

8.  NF-κB activity is inversely correlated to RNF11 expression in Parkinson's disease.

Authors:  Elaine Pranski; Carson D Van Sanford; Nirjari Dalal; Adam L Orr; Dipan Karmali; Deborah S Cooper; Marla Gearing; James J Lah; Allan I Levey; Ranjita Betarbet
Journal:  Neurosci Lett       Date:  2013-05-10       Impact factor: 3.046

Review 9.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

10.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.